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[(Figure_1)TD$FIG]Figure 1. Zika virus infection presenting with a generalized maculopapular rash: (A) upper body; (B) and (C) right arm; (D) skin of the palm, with reddish maculae.A 25-year-oldwoman presented to the outpatient clinicwith an
acute onset of a generalized itching rash after a 1-month holiday in
Brazil. During her ﬂight home she had started experiencing fever,
chills, myalgia, and headache. Two days later, these symptoms
improved spontaneously, but she noticed the appearance of an
itching rash. On examination the patient was afebrile and
displayed a generalized maculopapular rash with accentuation
of the hair follicles and involvement of the palmar and plantar skin
(Figure 1), as well as of themucosa of the hard palate, accompanied
by generalized lymphadenopathy. A full blood count revealed
leukocytopenia and slightly elevated C-reactive protein. Serumhttp://dx.doi.org/10.1016/j.ijid.2016.11.004
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).antibody tests were negative for Zika virus (ZIKV). The patient’s
symptoms resolved completely without treatment during the
following days. However, 14 days after her initial presentation,
ZIKV-IgM antibodies (Euroimmun ZIKV-ELISA, Lu¨beck, Germany),
as well as ZIKV neutralizing antibodies, were detectable in serum
specimens. Retrospectively, the ZIKV RT-PCR1 was positive in
serum obtained at the ﬁrst presentation with the generalized
maculopapular rash and negative ZIKV serology.
As exempliﬁed in this case, the serological diagnosis of ZIKV
infection can be difﬁcult, as speciﬁc IgM starts to be detectable only
at day 5 after the onset of clinical symptoms. In contrast, viraemiaciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Medical Imagery / International Journal of Infectious Diseases 54 (2017) 13–1414is brief, and direct virus detection in the blood is most sensitive
between days 3 and 5. Direct virus detection can be performed in
urine samples for up to 2 to 3weeks, allowing for proof of infection
in patients presenting later in their clinical course.2,3 ZIKV
infections remain mainly asymptomatic. Approximately 20% can
develop clinical symptoms such as rashes as dermatological
presentations, as in the patient case presented here.4,5
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